TCT-312 4-year Clinical Results of a Randomized trial Evaluating the Absorb Bioresorbable Vascular Scaffold vs. Metallic Drug-eluting Stent in de novo Native Coronary Artery Lesions: Data from the ABSORB Japan Trial

Abstract

The 3-year results of Absorb Japan presented showed a relatively high incidence of very late scaffold thrombosis in everolimus-eluting bioresorbable vascular scaffold (BVS) compared to cobalt-chromium everolimus-eluting stent (CoCr-EES). The question remains whether events of scaffold thrombosis